PaxMedica, Inc.
PXMD
$0.0001
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.79% | 0.14% | 38.71% | 154.62% | 217.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.47% | 25.02% | 52.25% | 125.62% | 134.04% |
| Operating Income | -2.47% | -25.02% | -52.25% | -125.62% | -134.04% |
| Income Before Tax | 26.43% | 11.46% | -23.56% | -425.41% | -579.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.43% | 11.46% | -23.56% | -425.41% | -579.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.43% | 11.46% | -23.56% | -425.41% | -579.59% |
| EBIT | -2.47% | -25.02% | -52.25% | -125.62% | -134.04% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 80.10% | 66.86% | 37.91% | -684.61% | -450.65% |
| Normalized Basic EPS | 80.61% | 66.51% | 32.20% | -5,657.50% | -386.91% |
| EPS Diluted | 80.08% | 66.85% | 46.17% | -225.46% | -651.21% |
| Normalized Diluted EPS | 80.61% | 66.51% | 33.35% | -2,682.61% | -395.84% |
| Average Basic Shares Outstanding | 606.85% | 456.96% | 223.46% | 86.24% | 74.95% |
| Average Diluted Shares Outstanding | 606.85% | 456.96% | 217.56% | 82.28% | 70.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |